Clinical trial
Phase 3 Alogliptin Pediatric Study
NCT02856113
Study timeline
Study start (actual)2016-10-14Date precision: day
Registry last updated2022-10-19
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Interventions
Alogliptin BenzoateDRUG · verified · RxNorm: alogliptin benzoate
PlaceboDRUG
Sponsors & collaborators
Takedalead sponsor
Takeda Development Center Americas, Inc.collaborator
Mapped research locations
Mexico CityMexico City, Mexico3GuadalajaraJalisco, Mexico2HoustonTexas, United States1ChicagoIllinois, United States1Los AngelesCalifornia, United States1DallasTexas, United States1St LouisMissouri, United States1MiamiFlorida, United States1SeattleWashington, United States1CincinnatiOhio, United States1TampaFlorida, United States1Washington D.C.District of Columbia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02856113 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.